Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997

Breast Journal

Volumn 10, Issue 5, 2004, Pages 433-439

  Du, Xianglin L ^a,d   Key, Charles R ^b   Osborne, Cynthia ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adjuvant therapy; Breast cancer; Chemotherapy; Hormone therapy; Population based; Women

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; HORMONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER STAGING; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; POPULATION RESEARCH; TUMOR REGRESSION; UNITED STATES;

AGE DISTRIBUTION; AGE FACTORS; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HORMONES; HUMANS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; NEW MEXICO; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 4644293320     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2004.21357.x     Document Type: Article

References (34)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women. N Engl J Med 1988;319:1681-92.
2. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1-15, 71-85.
3. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998;351:1451-67.
4. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med 1998;339:1609-18.
5. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-95.
6. NIH Consensus Conference. Adjuvant chemotherapy for breast cancer. JAMA 1985;254:3461-63.
7. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001;93:979-89.
8. Harlan LC, Abrams J, Warren JL, Clegg L, Stevens J, Ballard-Barbash R. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol 2002;20:1809-17.
9. Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst 2002;94:1626-34.
10. Osteen RT, Cady B, Chmiel JS, et al. The 1991 national survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg 1994;178:213-19.
11. Wilson RE, Donegan WL, Mettlin C, Natarajan N, Smart CR, Murphy GP. The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet 1984;159:309-18.
12. Vana J, Vana J, Bedwani R, Mettlin C, Murphy GP. Trends in diagnosis and management of breast cancer in the U.S.: from the surveys of the American College of Surgeons. Cancer 1981;48:1043-52.
13. Chu J, Diehr P, Feigl P, et al. The effect of age on the care of women with breast cancer in community hospitals. J Gerontol 1987;42:185-90.
14. Osteen RT, Karnell LH. The National Cancer Data Base report on breast cancer. Cancer 1994;73:1991-2000.
15. Solin LJ, Schultz DJ, Hanchak NA, Kessler HB. Patterns of treatment for older women with newly diagnosed breast carcinoma. Am J Clin Oncol 1999;22:107-13.
16. Solin LJ, Fowble BL, Martz KL, Goodman RL, Hanks GE. Results of the 1983 patterns of care process survey for definitive breast irradiation. Int J Radiat Oncol Biol Phys 1991;20:105-11.
17. Alien C, Cox EB, Manton KG, Cohen HJ. Breast cancer in the elderly. Current patterns of care. J Am Geriatr Soc 1986;34:637-42.
18. Silliman RA, Guadagnoli E, Rakowski W, et al. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol 2002;20:2680-88.
19. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1994. NIH publication no. 97-2789. Bethesda, MD: National Cancer Institute, 1997.
20. New Mexico Tumor Registry. About the New Mexico Tumor Registry. Available at http://hsc.unm.edu/epiccpro/nmtr.html; accessed November 8, 2002.
21. National Cancer Institute. The SEER Program Code Manual, rev. ed. NIH publication no. 94-1999. Bethesda, MD: National Cancer Institute, 1994.
22. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. Cary, NC: SAS Institute, 1997.
23. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000;92:550-56.
24. Du XL, Freeman JL, Freeman DH, Syblik DA, Goodwin JS. Temporal and regional variation in the use of breast conserving surgery and radiotherapy for older women with early stage breast cancer from 1983 to 1995. J Gerontol (Med Sci) 1999;54:474-78.
25. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001;285:885-92.
26. Du XL, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol 2001;19:1455-61.
27. Du XL, Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer 2001;92:730-37.
28. Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002;20:4636-42.
29. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med 2003;13S:90-97.
30. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002;347:567-75.
31. Shekelle PG, Ortiz E, Rhodes S, et al. Validity of the Agency for Healthcare Research and Quality Clinical Practice guidelines: how quickly do guidelines become outdated? JAMA 2001;286:1461-67.
32. Field MJ, Lohr KN. Guidelines for Clinical Practice: From Development to Use. Washington, DC: National Academy Press, 1992.
33. Woolf SH, Grol R, Hutchinson A, Eccles MP, Grimshaw J. Clinical practice guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999;318:527-30.
34. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-48.